partnering

News

Regeneron, AZ team up on drugs for obesity "superpower" gene

AstraZeneca has formed a partnership with Regeneron to investigate the potential of treating obesity using drugs directed at GPR75, a protective gene identified by scientists at the Regener

News

Biogen builds MS pipeline via $125m deal with China's InnoCa...

Biogen has moved to shore up its besieged multiple sclerosis franchise by licensing a BTK inhibitor from Chinese biotech InnoCare currently in mid-stage clinical testing.

News

Novo Nordisk bulks up in rare diseases with $1.2bn Prothena ...

Diabetes giant Novo Nordisk has opened a new front in its rare disease R&D, thanks to an acquisition agreement with Prothena focusing on drugs for ATTR amyloidosis.

News

Almirall kicks off another hunt for skin disease therapy par...

Spanish drugmaker Almirall has launched another search for early-stage research projects that it can partner in dermatology, its core area of expertise.

News

Nestle gets closer to Seres, pledging $525m for microbiome C...

Swiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million upfront for North American co-marketing rights to its lead drug for

News

BMS pays $650m upfront for Eisai's first ADC candidate for c...

Japan's Eisai has hit the jackpot with its first ever antibody-drug conjugate (ADC) drug candidate, attracting a licensing deal from Bristol-Myers Squibb that could top out at more than $3.

Regeneron, AZ team up on drugs for obesity "superpower" gene

Biogen builds MS pipeline via $125m deal with China's InnoCa...

Novo Nordisk bulks up in rare diseases with $1.2bn Prothena ...

Almirall kicks off another hunt for skin disease therapy par...

Nestle gets closer to Seres, pledging $525m for microbiome C...

BMS pays $650m upfront for Eisai's first ADC candidate for c...

Hims & Hers launches weight-loss business in UK

How to meet your physicians where they are online

partnering

Editor's Picks